4.3 Article

Hypertension and hypertension severity in Hispanics/Latinx with MS

Journal

MULTIPLE SCLEROSIS JOURNAL
Volume 27, Issue 12, Pages 1894-1901

Publisher

SAGE PUBLICATIONS LTD
DOI: 10.1177/13524585211019243

Keywords

Multiple sclerosis; hypertension; Hispanic; Latinx; disability

Funding

  1. NMSS [RG-1607-25324, FP-1708-29013]

Ask authors/readers for more resources

In Latinx individuals with MS, hypertension was found to be the most common vascular comorbidity and was significantly associated with a higher risk of disability. The study also highlighted the higher prevalence of hypertension and smoking in the older age group. Future research should focus on assessing the effectiveness of hypertension treatment in preventing disability in MS.
Background: Vascular comorbidities (VCs) including hypertension (HTN) are associated with worse multiple sclerosis (MS) outcomes. HTN is common in Latinx, but the prevalence and relationship with disability are unknown in Latinx with MS. Methods: Latinx (n = 451) from the Alliance for Research in Hispanic MS (ARHMS) seen between 2007 and 2019 were included. HTN, diabetes (DM), hyperlipidemia (HLD), ischemic events, and smoking were considered VC. Blood pressures (BPs) were classified using the American Heart Association (AHA) criteria. Logistic regression determined associations between VC and ambulatory disability accounting for age, sex, and disease duration. Results: Medical comorbidities were found in 41.9% and VC in 24.2%. Smoking (13.6%) and HTN (7.3%) were the most common. HTN was the most common over the age of 40 (12.6%). The odds of having severe disability were three times higher for those with HTN (odds ratio [OR], 3.12; 95% confidence interval (CI), 1.37-7.12). Stage II HTN according to AHA also tripled the odds (OR, 2.89; 95%CI, 1.11-7.55). AHA BP confirmed HTN in 27.5% (compared to 7.3% with established diagnosis). Conclusion: HTN diagnosis and stage II HTN defined by AHA were independently associated with severe ambulatory disability in Latinx with MS. HTN was underdiagnosed. Future studies should assess whether HTN treatment control would prevent disability in MS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available